Developing next generation oncology medicines through:

Novel scientific approach focused on harnessing critical cell-to-cell communications needed to revive the body’s ability to recognize, contain and eliminate abnormal cells found in cancer and potentially malignant conditions

Building a robust pipeline of proprietary biomarker targeted therapies to treat cancers with high unmet need

Our team brings deep oncology and organization building experience

Go to Top